| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 18,671 | 22,506 | 24,060 | 18,073 | | Cost of Revenue | 15,835 | 18,533 | 19,316 | 15,017 | | | Gross Profit | 2,836 | 3,973 | 4,744 | 3,056 | | | Operating Expenses | | Research Development | 524 | 479 | 539 | 521 | | Selling General and Administrative | 3,334 | 3,193 | 3,740 | 3,404 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,022) | 301 | 465 | (869) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (84) | 8 | 163 | 142 | | Earnings Before Interest And Taxes | (1,106) | 309 | 628 | (727) | | Interest Expense | (61) | 33 | 28 | 23 | | Income Before Tax | (1,045) | 276 | 600 | (750) | | Income Tax Expense | (293) | 64 | 242 | (421) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (752) | 212 | 358 | (329) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (752) | 212 | 358 | (329) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($752) | $212 | $358 | ($329) |
|
0.46% Nasdaq 
0.04 (1.06%) 
Income Statement
